Two recent studies suggest that GLP-1 drugs, commonly prescribed for diabetes and weight loss, can also reduce the occurrence and severity of serious infections including tuberculosis. This discovery highlights potential secondary health benefits of the medications that extend beyond their primary metabolic functions.